Enzon Pharmaceuticals Inc. (ENZN): Gap filled, we can move up now

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Tuesday, 12/15/2015 11:49:29 AM

Tuesday, December 15, 2015 11:49:29 AM

Gap filled, we can move up now

Keep Last Read

Next 10 Prev Next

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/19/2024 09:47:00 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/08/2024 08:36:22 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/08/2024 08:33:37 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/08/2024 08:32:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:06:02 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/29/2024 08:40:58 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/11/2024 09:01:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:05:28 PM
Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 05/22/2024 08:11:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:05:33 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:07:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:44 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:10 PM

InvestorsHub NewsWire

Only $200 per official company press release!